XWAR
PCR
Market cap337mUSD
Jul 10, Last price
64.00PLN
1D
1.59%
1Q
-6.43%
Jan 2017
-5.60%
IPO
86.15%
Name
PCC Rokita SA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PCC Rokita SA operates as a prominent producer and global supplier of chemical products, with operations extending across Poland and international markets. The company's diverse portfolio encompasses essential chemical categories such as chloralkali, polyurethanes, and a wide range of specialty products. Its core offerings further include key raw materials and intermediates, surfactants, various polyols, naphthalene, and phosphorus derivatives. PCC Rokita's extensive chemical solutions cater to a vast array of industrial applications and sectors, including adhesives, agrochemicals, building & construction, chemical reagents, detergents, fire prevention, the food & fuel industry, furniture manufacturing, industrial cleaning, lubricants & metalworking fluids, base oils, metallurgy, mining & drilling, oilfield operations, packaging, paints & coatings, personal care, pharmaceuticals, plastics, power generation, printing ink, pulp & paper, refrigeration & household appliances, sports & recreation, tanning & textile, transportation, vehicle cleaning & care, and water & wastewater treatment. Headquartered in Brzeg Dolny, Poland, PCC Rokita SA is an affiliate of the PCC SE group.
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||